ITOS: iTeos Therapeutics Inc Kompaniya qiymatining sof foydaga nisbati
Narxlar tendentsiyasining vizualizatsiyasi iTeos Therapeutics (ITOS) kompaniyasining ulkan ilmiy xarajatlar orqali ilg'or o'simtaga qarshi agentlarni yaratish yo'lidagi faoliyatini baholashga yordam beradi. Joriy ko'rsatkich -2.30 hisoblanadi. Biznes model GSK bilan hamkorlikka tayanadi, u sinov xarajatlarini qoplaydi, shuningdek, yangi immunoterapiya usullarini joriy etish uchun Belgiya va AQShda ishlab chiqarish quvvatlarini rivojlantirishni qamrab oladi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_ITOS_-_iTeos-Therapeutics_-_PE-Multiple "ITOS: iTeos Therapeutics Biznesning o‘zini qoplash muddati 04.07.2022 - 14.09.2025 | 👁️GURU.Markets👁️")
iTeos (ITOS) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati iTeos Therapeutics|ITOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati iTeos Pharma|ITOS - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati iTeos Therapeutics, Inc.|ITOS - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz iTeos Therapeutics|Oraliq qoplama koeffitsiyenti iteostherapeutics.com
- foyda va bozor multiplikatorlari tafsilotlari:
ITOS - Sof daromad|Kelajakdagi sof foyda iTeos Therapeutics|ITOS - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati iTeos Therapeutics Inc|ITOS - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati iTeos Therapeutics, Inc.|ITOS - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda iTeos Therapeutics|ITOS - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi iteostherapeutics.com|ITOS - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi iTeos Therapeutics
Kompaniyaning har tomonlama tahlili:iteostherapeutics.com ITOS
Yuqori sifatli aktivlarni tanlash uchun investor qat'iy fundamental baholash mezonlariga tayanishi kerak. Ushbu ko'rsatkich aksiyaning bozor narxining sof foydaga nisbatini belgilab, kapitalning har bir birligi uchun daromad yaratish samaradorligini o'lchaydi. Innovatsion T-hujayrali immunoterapiyani ishlab chiquvchi iTeos Therapeutics (ITOS) uchun ushbu nisbat onkologiya sohasidagi kelajakdagi yutuqlarga bo'lgan bozor kutuvlarini aks ettiradi. iTeos Therapeutics ning konsolidatsiyalashgan P/E ko'rsatkichi tahlili biofarmatsevtika sektoridagi tebranishlar fonida biznesning xavfsizlik zaxirasini baholash imkonini beradi. Kompaniyaga tegishli konsolidatsiyalashgan P/E tendentsiyasi o'sish potentsialini yoki aktivlarning qadrsizlanishi xavflarini ko'rsatadi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|Biznesning o‘zini qoplash muddati Tourmaline TRML|PGEN (Precigen, Inc.) - Narx-foyda koeffitsiyenti|PHAR: Bozor narxining sof foydaga nisbati|NKTR (Nektar Therapeutics Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Upstream Bio, Inc. UPB|Narxning foydaga nisbati Zenas Biopharma, Inc. (ZBIO)|IMNM - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Gossamer Bio, Inc. GOSS|Biznesning o‘zini qoplash muddati kalvista.com (KALV)|SEPN: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PVLA (Pieris Pharma)|SVRA (Savara Corp) - Narx-foyda koeffitsiyenti|RIGL: Bozor narxining sof foydaga nisbati|ANAB (AnaptysBio, Inc.) - P/E multiplikatori|ATXS: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ENGN|RAPT - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Aerovate Therapeutics JBIO|Kompaniya qiymatining sof foydaga nisbati ACRS|Kyverna Therapeutics - P/E multiplikatori|TLSA - P/E multiplikatori|Cabaletta Bio (CABA) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati VTYX (Ventyx Biosciences Inc.)|THTX (Theratechnologies Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Avalo Therapeutics Inc AVTX|Narx-foyda koeffitsiyenti ELDN (Eledon Pharmaceuticals)|P/E multiplikatori agenusbio.com (AGEN)|Climb Bio - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati ZURA (Zura Bio Ltd)|aTyr - P/E multiplikatori|Biznesning o‘zini qoplash muddati Adagene ADAG|IMA: P/E multiplikatori|Narx-foyda koeffitsiyenti Shattuck Labs|Narxning foydaga nisbati Equillium Inc|Connect Pharma (CNTB) - Biznesning o‘zini qoplash muddati|P/E multiplikatori IMUX|Biznesning o‘zini qoplash muddati atarabio.com|InflaRx - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati XFOR (x4pharma.com)|ACET - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Celularity Inc.|INmune Bio Corp (INMB) - Narxning foydaga nisbati|BRNS - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Kezar Life Sciences|sabbiotherapeutics.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori AKTX|ENLV (enlivex.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori QTTB (Q32 Bio)|P/E multiplikatori GeoVax Corp GOVX|EDSA - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati IBIO (ibioinc.com)|carismatx.com (CARM) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti XTL Biopharmaceuticals Ltd|BOLT (Bolt Biotherapeutics Inc.) - P/E multiplikatori|P/E multiplikatori HCW Biologics Inc|Narx-foyda koeffitsiyenti APVO (Aptevo Therapeutics)|AIM (AIM ImmunoTech, Inc.) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADTX (Aditxt, Inc.)|Biznesning o‘zini qoplash muddati GRI Bio Inc (GRI)|XRTX - Narxning foydaga nisbati|Vyome Therapeutics (HIND) - Narx-foyda koeffitsiyenti|Revelation Biosciences (REVB) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti indaptusrx.com|Narx-foyda koeffitsiyenti SCNI|P/E multiplikatori CalciMedica Corp|Narxning foydaga nisbati Affimed (AFMD)|allakos.com - Narx-foyda multiplikatori|P/E multiplikatori HOOK (HOOKIPA Pharma)|IGM Biosciences Inc. (IGMS) - Kapitalizatsiyaning foydaga nisbati|Ocean Biomedical - P/E multiplikatori|Biznesning o‘zini qoplash muddati TC BioPharm (Holdings) Plc TCBP|THRD (Third Harmonic Bio, Inc) - Narx-foyda koeffitsiyenti
